Interviews

twitter

more news

Childhood Cancer 2017

18th / 19th September, Newcastle
Two-day meeting focused on translational research for patient benefit.

register for updates

Interviews

We are pleased to share footage from ecancer, who joined us at Childhood Cancer 2016 to interview some of our speakers.

Professor Persis Amrolia, Great Ormond Street Hospital for Children, UK
Persis co-chaired day two of the conference and talks to ecancer about the day’s presentations and discussions:
Professor John Anderson, UCL Institute of Child Health, UK
John co-chaired day two of the conference and reflects on the day’s proceedings:
Dr Nai-Kong Cheung, Memorial Sloan Kettering Cancer Center, USA
Nai-Kong talks to ecancer about his pioneering work using antibody-based and bispecific T-cell dependent therapies in childhood solid tumours:
Dr Daniel Lee, University of Virginia, USA
Daniel talks about his CAR T-cell trials at NCI: CD19 CAR T-cell therapy for ALL and B-cell lymphoma and GD2 CAR T-cell therapy for osteosarcoma and neuroblastoma:
Dr Stephan Grupp, The Children's Hospital of Philadelphia, USA
Stephan talks to ecancer about his pioneering work using engineered cell therapy in refractory paediatric acute lymphoblastic leukaemia:
Dr Sara Ghorashian, UCL Institute of Child Health, UK
Sara talks to ecancer about her proffered paper ‘Vaccination to improve the persistence of CD19 CAR gene-modified T-cells in relapsed pediatric acute lymphoblastic leukemia’:
Anne Kramer, UCL Institute of Child Health, UK
Anne talks to ecancer about her proffered paper ‘Delineating the impact of scFv affinity on CAR-mediated T-cell function’:
Professor Denis Henshaw, Scientific Director, Children with Cancer UK
Denis chaired day three of the conference and talks to ecancer about environmental causes of childhood cancer:
Professor Soterios Kyrtopoulos, National Hellenic Research Foundation, Greece
Soterios discusses the NewGeneris project, focusing on the effect of maternal dietary carcinogens during pregnancy on cancer risk in children:
Dr Kurt Straif, International Agency for Research on Cancer, France
Kurt speaks to ecancer about his conference presentation 'What do we know about risk factors for childhood cancer and what are the challenges in ongoing research?'
Dr Mark Miller, University of California San Francisco & California Environmental Protection Agency, USA
Mark discusses efforts towards primary prevention of childhood cancer and whether we can reduce exposure to associated risk factors:
Dr Gerald Kendall, University of Oxford, UK
Gerry talks to ecancer about his proffered paper ‘Childhood leukaemia and natural background radiation’:
Jessica Timms, Newcastle University, UK
Jessica talks to ecancer about her proffered paper ‘DNA methylation as a mediator of in utero exposures on risk of childhood acute lymphoblastic leukaemia’:
Dr Gisele Brisson, Instituto National de Cancer, Rio de Janeiro, Brazil
Gisele talks to ecancer about her proffered paper ‘NQO1, GSTM1 and GSTT1 polymorphisms are associated with childhood acute myeloid leukaemia subtypes and type I mutations’:
Professor Mehmet Dorak, Liverpool Hope University, UK
Mehmet speaks to ecancer about his proffered paper ‘Making sense of genetic associations with childhood leukaemia risk’: